German firms pep up Vietnam’s healthcare market
09-Dec-14, Vietnam Investment Review
Fabrice Leguet, head of Siemens Healthcare in Vietnam, told VIR that Siemens “is proud to be the number one supplier of diagnostics solutions in the Vietnamese market, combining the strengths of both in vitro and imaging diagnostics.”
“We aim to supply Vietnamese healthcare providers with the most innovative medical technologies to properly diagnose and treat patients,” he said. “For some patients, availability of the equipment is a question of life or death. For investors, it’s a question of getting the most out of their investment."
German leading healthcare product maker B. Braun Melsungen AG has planned to raise its compound investment capital in Vietnam to $270 million over the next seven to nine years with most of the investment made within the next two to three years.
Other firms like Boehringer Ingelheim International, Draeger Medical Vietnam, Rudolf J.H Lietz, Fresenius Kabi, Bayer Schering Pharma, and Merck are also operating successfully in Vietnam.